General Hospital of Kavala
- Address
- 13th September str., 65302 Kavala, Greece
General Hospital of Kavala - Ophthalmology Research Center
The General Hospital of Kavala is a clinical research facility with demonstrated expertise in ophthalmology, particularly in the evaluation of treatments for ocular conditions. The center specializes in conducting rigorous clinical trials comparing therapeutic interventions for patients with elevated intraocular pressure and related eye disorders.
- Open angle glaucoma treatment studies
- Ocular hypertension management research
- Generic medication bioequivalence and non-inferiority trials
The center has established protocols for assessing intraocular pressure (IOP) management using both innovative and reference pharmaceutical products. Their research focuses on fixed-combination ophthalmic therapies, including carbonic anhydrase inhibitors and beta-blockers, contributing valuable data to ensure effective and accessible treatment options for patients with glaucoma and ocular hypertension.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in General Hospital of Kavala
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Non-Inferiority Trial of Brinzolamide-Timolol Versus Azarga in Reducing Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension | OmniVision GmbH | Phase III | Not Recruiting | Jul 2024 | May 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Brinzolamide | 1 | Unknown | 2024-07-15 | 2024-07-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.